NCT Number: NCT05946824
Phase: PHASE2
Trial Summary: There is significant, proven use of radiation for recurrent prostate cancer after surgical resection. This treatment typically is delivered over seven and a half weeks of daily treatments, presenting – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Celcuity Inc
Acronym: DASBRT-RPC
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives